Dr Horst K Schirmer, MD in Butler, MD - Urology

Dr Horst K Schirmer, MD is a Urology physician based in Butler, Maryland. Dr Horst K Schirmer is licensed to practice in Maryland (license number D0010775) and his current practice location is 14007 Falls Road, Butler, Maryland. He can be reached at his office (for appointments etc.) via phone at (410) 584-2865.

NPI number for Dr Horst K Schirmer is 1972763902 and his current mailing address is Po Box 38, 14007 Falls Road, Butler, Maryland. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1972763902.

Contact Information

	Dr Horst K Schirmer, MD
	14007 Falls Road, Butler, MD 21023-0038
	(410) 584-2865
	(410) 584-2865

Physician's Profile

Full Name	Dr Horst K Schirmer
Gender	Male
Speciality	Urology
Location	14007 Falls Road, Butler, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1972763902
Provider Enumeration Date: 06/12/2008
Last Update Date: 06/12/2008

Medical Identifiers

Medical identifiers for Dr Horst K Schirmer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1972763902	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	D0010775 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Horst K Schirmer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Horst K Schirmer, MD Po Box 38, 14007 Falls Road, Butler, MD 21023-0038 Ph: (410) 584-2865	Dr Horst K Schirmer, MD 14007 Falls Road, Butler, MD 21023-0038 Ph: (410) 584-2865

News Archive

LSDF announces $15M in program grant to enhance diagnosis and treatment of cancer

The Life Sciences Discovery Fund today announced nearly $15 million in program grant awards to support collaborative research initiatives spearheaded by three Washington state life sciences organizations.

Researchers propose new strategy for developing drugs based on inhibition of tyrosine kinases

A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (USA) proposes a new strategy for the development of new drugs based on the inhibition of tyrosine kinase enzymes, molecules that activate and trigger many cellular processes. The results have been published in the Chemistry - A European Journal.

Scientists identify new drug target to combat chikungunya virus

Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.

Denmark researchers calculate the real burden of foodborne infections

Campylobacter is the foodborne bacteria that contributes most to the burden of disease in Denmark. This is the finding of a study from the National Food Institute, Technical University of Denmark, which for the first time in Denmark ranks three foodborne bacteria according to the burden of disease they impose on society as a whole.

Dr Horst K Schirmer, MD - Urology in Butler, MD